-
Nilesh Gupta Sets Target at $5 billion by 2018
“I’ll be 40 soon,” quipped 39-year-old Nilesh Gupta, who takes…
Read more -
Habil Khorakiwala in Panic as Chikalthana plant Report is awaited!
An FDA import alert can cause Rs 1,200 cr loss…
Read more -
Clinical Trials India is in Danger?
The government must ensure ethical clinical trials, a critical part…
Read more -
Indian Pharma Policy makers lapse create shortage of essential medicines
MUMBAI: A shortage of essential medicines is looming across major…
Read more -
Sharma says govt looking at concerns over FDI in pharmaCommerce and Industry Ministry has also raised serious concerns over the spate of mergers and acquisitions of Indian pharma companies. ‘Negative narrative’ cast adverse impact on economy:
Government is looking at concerns raised by many over FDI…
Read more -
India pharma companies should follow strict regulations: FDA
Washington: The Food and Drug Administration (FDA) is not singling…
Read more -
Indian Pharma Sector is today Directionless from Govt!
Mylan, the third largest generic pharmaceuticals company in the world,…
Read more -
The DIPP is in favour of restrictions on at least three categories of pharmaceuticals – vaccines, injectibles and oncology (cancer) medicines.
The Industry Department (DIPP) is proposing to extend restrictions on…
Read more -
India receives highest FDI worth $1 bn in pharma in Apr-JunThis, amid concerns over increasing acquisitions of doemestic firms by multinationals
India’s pharmaceuticals sector has received FDI of $1 billion, the…
Read more -
DCGI Gives Ranbaxy Breather, Ranbaxy Loss May cross 1 Billion $
Ranbaxy’s derivative losses may cross $1 bn Drug maker may…
Read more